Patients with MPA and with positivity for MPO-ANCA are predominant in Asian countries, whereas patients with GPA and with positivity for PR3-ANCA are predominant in northern Europe and the United States [6]. The gene discussed is MPO; the disease is granulomatosis with polyangiitis.